4//SEC Filing
ADAMIS ANTHONY P 4
Accession 0001562180-23-005447
CIK 0001314102other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 9:18 AM ET
Size
7.6 KB
Accession
0001562180-23-005447
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-20+13,000→ 13,000 totalExercise: $3.50From: 2024-02-23Exp: 2033-06-19→ Common Stock (13,000 underlying) - Award
Stock Option (Right to Buy)
2023-06-20+26,100→ 26,100 totalExercise: $3.26From: 2024-01-06Exp: 2033-06-19→ Common Stock (26,100 underlying)
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001277479
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 9:18 AM ET
- Size
- 7.6 KB